XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Comprehensive Deficit
BALANCE, at beginning of period (in shares) at Dec. 31, 2022   7,025,000    
BALANCE, at beginning of period at Dec. 31, 2022 $ 76,379 $ 7 $ 357,924 $ (281,552)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Non-cash compensation recognized on stock options and employee stock purchase plan ("ESPP") 30   30  
Restricted stock grants, net of cancellations (in shares)   227,000    
Restricted stock grants, net of cancellations 4,806   4,806  
Cancellation of shares for payment of withholding tax (in shares)   (47,000)    
Cancellation of shares for payment of withholding tax (496)   (496)  
ESPP shares issued (in shares)   2,000    
ESPP shares issued 15   15  
Common shares issued in settlement and prepayment of notes payable (in shares)   2,141,000    
Common shares issued in settlement and prepayment of notes payable 19,052 $ 2 19,050  
Net loss $ (24,396)     (24,396)
BALANCE, at end of period (in shares) at Dec. 31, 2023 9,347,979 9,348,000    
BALANCE, at end of period at Dec. 31, 2023 $ 75,390 $ 9 381,329 (305,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Non-cash compensation recognized on stock options and employee stock purchase plan ("ESPP") 19   19  
Restricted stock grants, net of cancellations (in shares)   677,000    
Restricted stock grants, net of cancellations 4,486   4,486  
Cancellation of shares for payment of withholding tax (in shares)   (163,000)    
Cancellation of shares for payment of withholding tax (286)   (286)  
ESPP shares issued (in shares)   5,000    
ESPP shares issued 5   5  
Issuance of Common Stock, Warrants, and Pre-Funded Warrants in connection with common stock offerings, net of issuance costs (in shares)   6,962,000    
Issuance of Common Stock, Warrants, and Pre-Funded Warrants in connection with common stock offerings, net of issuance costs 9,839 $ 8 9,831  
Issuance of Common Stock for Pre-Funded Warrants Exercise (in shares)   844,061    
Issuance of Common Stock for Pre-Funded Warrants Exercise 0 $ 1 (1)  
Net loss $ (48,697)     (48,697)
BALANCE, at end of period (in shares) at Dec. 31, 2024 17,673,404 17,673,000    
BALANCE, at end of period at Dec. 31, 2024 $ 40,756 $ 18 $ 395,383 $ (354,645)